These projects are funded by grants from European funding bodies (e.g., Horizon 2020, Innovative Medicines Initiative, IMI 2) and services provided to industry sponsors, for example.
Before receiving sustainable support from its member and observer countries, ECRIN was developed and matured through a series of five EU-funded projects (FP6, FP7 and H2020). ECRIN was created in 2004 with the goal of supporting mostly academic sponsors and investigators across Europe to overcome the barriers to multinational clinical research. ECRIN’s first European project (ECRIN-RKP, 2004-05) focused on strategy, the second (ECRIN-TWG, 2006-08) on tools, and the third (ECRIN-PPI, 2008-12) on infrastructure development.